Evidence

Displaying 21 - 30 of 131, sorted by most recent

form.antibot { display: none !important; } You must have JavaScript enabled to use this form.

Case Commentary: Saada v. Golan, 833 Fed. App'x 829 (2d Cir. 2021)

James D. Garbolino

November 17, 2022

Motion to Set Aside

In this case, a motion to set aside judgment under Rule 60(b) was denied for failure to raise material disputed fact. The party must show evidence of a disputed material to support a motion to set aside a judgment based on newly discovered evidence.

COVID-19 and the U.S. District Courts: An Empirical Investigation

Roy P. Germano, Timothy T. Lau, Kristin A. Garri

October 29, 2022

This report uses caseload data to examine case-processing trends in the United States district courts during the COVID-19 pandemic.

Term Talk: U.S. v. Zubaydah, F.B.I. v. Fazaga

Paul Clement, James A. Chance

September 14, 2022

State Secrets Privilege. FISA. Experts discuss the interplay between the common law State Secrets Privilege and the statutory Foreign Intelligence Surveillance Act (FISA).

Amendments to the Federal Rules of Practice and Procedure 2023—Transmittal to the Judicial Conference

August 23, 2022

This package of materials was transmitted to the Judicial Conference, and it includes proposed amendments to the Federal Rules of Practice and Procedure to become effective on December 1, 2023.

Case Commentary: Nowlan v. Nowlan, Civil Action No. 5:20cv00102, 2021 U.S. Dist. LEXIS 10824 (W.D. Va. Jan. 21, 2021)

James D. Garbolino

March 19, 2021

Videoconference Testimony | Sixth Amendment Right to Confront and the Hague Convention

In this case, the petitioner made a pretrial request to appear by videoconference.

Holdings

Case Commentary: Pope v. Lunday, No. 20-6003, 2020 U.S. App. LEXIS 36618 (10th Cir. Nov. 20, 2020)

James D. Garbolino

February 16, 2021

Habitual Residence of Infants | Lack of Necessity of Evidentiary Hearing

Summary

Irene M. Keeley

December 3, 2020

In concluding remarks, Judge Irene Keeley (N.D. W.

Treatment of Incarcerated Individuals with Opioid Use Disorders

Cathy Thompson

December 3, 2020

Dr.

Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings

Christopher Jones, Hanna Umanskiy Ortiz

December 3, 2020

Dr. Christopher Jones, U.S. Public Health Service and Centers for Disease Control and Prevention (CDC), reviews current options (to include methadone, buprenorphine and naltrexone) in Medication-Assisted Treatment (MAT) for those with an opioid use disorder.

Biology, Neurobiology, and Chemistry of Opioid Use Disorder

Wilson Compton, Jason A. Cantone

December 3, 2020

Dr. Wilson Compton, deputy director of the National Institute on Drug Abuse (NIDA), explains what judges need to know about the biology, neurobiology, and chemistry of opioid use disorder.

Federal Judicial Center

You are here

Evidence

Case Commentary: Saada v. Golan, 833 Fed. App'x 829 (2d Cir. 2021)

COVID-19 and the U.S. District Courts: An Empirical Investigation

Term Talk: U.S. v. Zubaydah, F.B.I. v. Fazaga

Amendments to the Federal Rules of Practice and Procedure 2023—Transmittal to the Judicial Conference

Case Commentary: Nowlan v. Nowlan, Civil Action No. 5:20cv00102, 2021 U.S. Dist. LEXIS 10824 (W.D. Va. Jan. 21, 2021)

Case Commentary: Pope v. Lunday, No. 20-6003, 2020 U.S. App. LEXIS 36618 (10th Cir. Nov. 20, 2020)

Summary

Treatment of Incarcerated Individuals with Opioid Use Disorders

Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings

Biology, Neurobiology, and Chemistry of Opioid Use Disorder

Pages